Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new atacand clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on atacand
- The Potential of Rosuvastatin and Candesartan to Retard the Progression of Aortic Stenosis
Status: Recruiting, Condition Summary: Aortic Valve Stenosis - Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Subjects With Dysglycemia and Abdominal Obesity - "ARAMIA"
Status: Recruiting, Condition Summary: Glucose Intolerance; Obesity - Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
Status: Completed, Condition Summary: Hypertension; Obesity - Angiotensin-II Blockade in Mitral Regurgitation
Status: Completed, Condition Summary: Mitral Regurgitation - Study to Characterize the Long-Term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years
Status: Enrolling by invitation, Condition Summary: Hypertension - A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
Status: Recruiting, Condition Summary: Hypertension; Obesity - Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France
Status: Recruiting, Condition Summary: Heart Failure; Cohort Study - Study to Demonstrate the Non-Inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-Type (or Brain) Natriuretic Peptide Levels at Week 24
Status: Not yet recruiting, Condition Summary: Chronic Heart Failure; High Blood B-Type (or Brain) Natriuretic Peptide (BNP) Level - Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
Status: Recruiting, Condition Summary: Primary Hypertension - Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension
Status: Recruiting, Condition Summary: Essential Hypertension - Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
Status: Completed, Condition Summary: Hypertension - Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)
Status: Completed, Condition Summary: Congestive Heart Failure - Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)
Status: Completed, Condition Summary: Congestive Heart Failure - Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)
Status: Completed, Condition Summary: Congestive Heart Failure - Candesartan Effect in Second Stage Arterial Hypertension
Status: Not yet recruiting, Condition Summary: Stage II Hypertension - Atacand (Candesartan) Real Life Study
Status: Recruiting, Condition Summary: Hypertension - Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide
Status: Completed, Condition Summary: Essential Hypertension - Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH
Status: Completed, Condition Summary: Essential Hypertension; Left Ventricular Hypertrophy - Candesartan Effectiveness Study in Pro-BNP
Status: Active, not recruiting, Condition Summary: Hypertension; Left Ventricular Hypertrophy - DIabetic Retinopathy Candesartan Trials
Status: Active, not recruiting, Condition Summary: Type 2 Diabetes - DIabetic Retinopathy Candesartan Trials.
Status: Active, not recruiting, Condition Summary: Type 1 Diabetes - Diabetic Retinopathy Candesartan Trials
Status: Active, not recruiting, Condition Summary: Type 1 Diabetes - Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
Status: Completed, Condition Summary: Hypertension - Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age
Status: Active, not recruiting, Condition Summary: Hypertension - ARIA(Atacand Renoprotection In NephropAthy Pt.)
Status: Recruiting, Condition Summary: Non-Diabetic Nephropathy With Hypertension - High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
Status: Completed, Condition Summary: Proteinuria - Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age
Status: Completed, Condition Summary: Pediatric Hypertension - Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age
Status: Completed, Condition Summary: Hypertension - Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
Status: Recruiting, Condition Summary: HIV Infections; Hypertension - CCB Safety Study in Treatment of Hypertension of ADPKD
Status: Not yet recruiting, Condition Summary: Kidney, Polycystic, Autosomal Dominant